The Joint Collector

Forget stamps: one bioengineer amasses broken artificial joints to learn why they failed and how to build better ones.

Written byHannah Waters
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

JOINT EFFORT: The Frank H. Stelling and C. Dayton Riddle Orthopaedic Research and Education Laboratory, where John DesJardins and colleagues investigate implant design, function, and longevity CRAIG MAHAFFEY

Some people drive more aggressively than others,” says bioengineer John DesJardins. But he’s not talking about cars; rather, he’s referring to artificial joints. As director of the orthopedic design and engineering lab at South Carolina’s Clemson University, he spends much of his time inspecting plastic and metal knee, hip, and shoulder replacements worn out by the reckless “driving” that is human locomotion.

More than 800,000 joints are now replaced each year in the United States, and DesJardins estimates that 90 percent of these surgeries go off without a hitch, and are still functional 10 years after surgery. However, the remaining 10 percent of artificial joints need to be replaced within that time period. These are the artificial joints that grab his attention. Since 2007, DesJardins ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies